Stay updated on Gemcitabine+Nivolumab in Metastatic Small Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Gemcitabine+Nivolumab in Metastatic Small Cell Lung Cancer Clinical Trial page.
Latest updates to the Gemcitabine+Nivolumab in Metastatic Small Cell Lung Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.1%
- Check19 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with the study's location.SummaryDifference3%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedSeveral key resources related to lung cancer and clinical trials have been removed, including links to MedlinePlus and Dailymed, which may impact access to important medical information.SummaryDifference5%
- Check41 days agoChange DetectedThe website has been updated to version 2.12.2, adding several new resources related to lung cancer, including links to MedlinePlus, Rare Diseases, and DailyMed, as well as clinical trial documents.SummaryDifference5%
- Check55 days agoChange DetectedThe website has been updated from version v2.12.0 to v2.12.1.SummaryDifference0.1%
- Check62 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential improvements or features.SummaryDifference0.2%
Stay in the know with updates to Gemcitabine+Nivolumab in Metastatic Small Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gemcitabine+Nivolumab in Metastatic Small Cell Lung Cancer Clinical Trial page.